BMC Gastroenterol

1. CHEN C, Zhang D, Huang S, Zeng F, et al
   Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial.
   BMC Gastroenterol. 2024;24:131.
   

   >> Share

   
   

   
   Dig Dis Sci

2. SATOH H, Akiba Y, Urushidani T, Kaunitz JD, et al
   Cholecystokinin-Induced Duodenogastric Bile Reflux Increases the Severity of Indomethacin-Induced Gastric Antral Ulcers in Re-fed Mice.
   Dig Dis Sci. 2024 Mar 6. doi: 10.1007/s10620-024-08352.
   

   >> Share

   
   
3. MATSUMURA T, Sonoda M, Okimoto K, Dao HV, et al
   Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
   Dig Dis Sci. 2024 Apr 15. doi: 10.1007/s10620-024-08411.
   

   >> Share

   
   

   
   Eur J Gastroenterol Hepatol

4. LIU J, Zhang T, Liu X, Wang Q, et al
   Causal effect between gut microbiota and gastroesophageal reflux disease: a bidirectional two-sample Mendelian randomization study.
   Eur J Gastroenterol Hepatol. 2024 Apr 15. doi: 10.1097/MEG.0000000000002774.
   

   >> Share

   
   

   
   Helicobacter

5. LIU J, Jia J, Shi T, Bai Y, et al
   Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target.
   Helicobacter. 2024;29:e13075.
   

   >> Share

   
   
6. MOFIDIFAR S, Yadegar A, Karimi-Jafari MH
   A reconstructed genome-scale metabolic model of Helicobacter pylori for predicting putative drug targets in clarithromycin and rifampicin resistance conditions.
   Helicobacter. 2024;29:e13074.
   

   >> Share

   
   

   
   Indian J Gastroenterol

7. PRAJAPATI SK, Senthamizhselvan K, Murugesan R, Mohan P, et al
   Utility of proximal mean nocturnal basal impedance in gastroesophageal reflux disease-A preliminary experience.
   Indian J Gastroenterol. 2024 Apr 15. doi: 10.1007/s12664-024-01573.
   

   >> Share

   
   

   
   Surg Endosc

8. HUO B, Calabrese E, Sylla P, Kumar S, et al
   The performance of artificial intelligence large language model-linked chatbots in surgical decision-making for gastroesophageal reflux disease.
   Surg Endosc. 2024 Apr 17. doi: 10.1007/s00464-024-10807.
   

   >> Share

   
   
9. SACHAR M, Wizentier MM, Risner E, Asmail H, et al
   Correction: Risk factors associated with functional esophageal disorders (FED) versus gastroesophageal reflux disease (GERD).
   Surg Endosc. 2024 Apr 15. doi: 10.1007/s00464-024-10846.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share